Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma.
Zi D, Li Q, Xu CX, Zhou ZW, Song GB, Hu CB, Wen F, Yang HL, Nie L, Zhao X, Tan J, Zhou SF, He ZX.
Zi D, et al. Among authors: tan j.
Aging (Albany NY). 2022 Nov 15;14(21):3891-3892. doi: 10.18632/aging.204735. Epub 2022 Nov 15.
Aging (Albany NY). 2022.
PMID: 36377208
Free article.
No abstract available.